Patent details

EP1907540 Title: IN-SOLUTION ACTIVATION OF FACTOR VII

Basic Information

Publication number:
EP1907540
PCT Application Number:
PCT/US/2006/028285
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068001833
PCT Publication Number:
WO/2007/013993
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IN-SOLUTION ACTIVATION OF FACTOR VII
French Title of Invention:
ACTIVATION EN SOLUTION DU FACTEUR VII
German Title of Invention:
AKTIVIERUNG VON FAKTOR VII IN DER FLÜSSIGEN PHASE
SPC Number:

Dates

Filing date:
21/07/2006
Grant date:
19/12/2012
EP Publication Date:
19/12/2012
PCT Publication Date:
01/02/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/04/2008
EP B1 Publication Date:
19/12/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/07/2013
Expiration date:
21/07/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/07/2006
 
 

Name:
Bayer HealthCare LLC
Address:
555 White Plains Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:
VISWANATHAN Sridhar
Address:
United States (US)

2

Name:
KREBBER Claus, M.
Address:
United States (US)

Priority

Priority Number:
702041 P
Priority Date:
22/07/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 9/64;
Filing date Document type Number of pages